Children's Medical Center
Dallas, Texas, 75235, United States
NCT Number: NCT03527459
The purpose of this project is to evaluate a set of interventions derived from a theory of suicide that supplements a clinical program and compare their effects on outcomes to the outcomes of the unsupplemented program. This study proposes to evaluate the effect of these interventions on reducing specific negative cognitions associated with depression and suicide ideation in an intensive outpatient program for suicidal youth (Suicide Prevention and Resilience at Children's, SPARC).
Looking for future studies?
Notify Me12 year–18 year
All sexes
Interventional
Not applicable
Dallas, Texas, 75235, United States
The trial will be conducted in a program where half of the clients are enrolled into either the original program (SPARC A which has a general focus on negative cognitions) or SPARC B (which will overlap significantly with SPARC A but targets in some sessions specific negative cognitions of perceived burdensomeness). The program is already structured so that each patient consistently attends either a morning or an afternoon track, with different therapists running each track. This allows for separate programs in each track. Clinically justifiable innovations are routinely introduced into the program usually in a stepwise fashion in one or another part by one set of therapists at a time. The investigators propose to take advantage of this partial introduction by assessing relative impact of SPARC A and SPARC B on depressive symptoms and suicide ideation. The investigators have no data to indicate that one program will be better than the other. The investigation will, however, allow the investigators to assess whether this innovation in fact is effective. Patients will not be randomized at the individual level, but rather their time slot (usually decided based on opening within the program) will place them into either SPARC A or SPARC B. The two programs are of identical length with numerous features in common, differing only in the specificity of the exercises and examples and their relevance to perceived burdensomeness. Routine assessments at entry and discharge from the program will not change based on study enrollment. However, suicide ideation, depressive symptoms, and negative cognitions (perceived burdensomeness and thwarted belongingness) will be more formally assessed at the one-month follow-up meeting or phone call which will add approximately 10 minutes to the contact.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SPARC B includes all aspects of the SPARC A clinical program, as well as targeting negative cognitions of perceived burdensomeness.
SPARC A is an existing clinical program with a general focus on negative cognitions.
Time frame: through program completion, an average of 6 weeks
change in perceived burdensomeness
Time frame: through program completion, an average of 6 weeks
suicide ideation (self-report)
Time frame: through program completion, an average of 6 weeks
change in depressive symptoms
Time frame: 1 month after program completion
change in perceived burdensomeness
Time frame: 1 month after program completion
change in suicide ideation (self-report)
Time frame: 1 month after program completion
change in depressive symptoms
Time frame: between program completion, an average of 6 weeks, and 1 month after program completion
change in suicide ideation (self-report)
University of Texas Southwestern Medical Center
Other
Implementing an Interpersonal Theory of Suicide Treatment Approach to Improve Outcomes in Suicidal Youth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06194331
Behavior, Behavioral Symptoms
Itasca, Illinois, United States
View Trial DetailsNCT05325944
Anxiety, Anxiety Disorders
Chicago, Illinois, United States
View Trial DetailsNCT04948268
Anxiety, Anxiety Disorders
Chicago, Illinois, United States
View Trial DetailsNCT03940508
Behavior, Behavioral Symptoms
New York, United States
View Trial Details